Real-world insights on the use of transversus abdominis plane block with liposomal bupivacaine in the multimodal management of somatic versus visceral pain in the colorectal surgery setting

Nicholas C Connolly Bend Anesthesiology Group, Bend, OR, USA Multimodal approaches are recommended to achieve effective postsurgical analgesia with reduced opioid reliance and are integral to enhanced recovery after surgery (ERAS) protocols. Transversus abdominis plane (TAP) block is a regional anal...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pain research 2018-01, Vol.11, p.1141-1146
Main Author: Connolly, Nicholas C
Format: Article
Language:English
Subjects:
Analgesia
Bupivacaine
Clinical trials
Colitis
Colorectal surgery
field block
Hospital patients
Laparoscopy
multimodal pain management
Narcotics
opioid
Pain
Pain management
postsurgical pain
Surgery
transversus abdominis plane block
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nicholas C Connolly Bend Anesthesiology Group, Bend, OR, USA Multimodal approaches are recommended to achieve effective postsurgical analgesia with reduced opioid reliance and are integral to enhanced recovery after surgery (ERAS) protocols. Transversus abdominis plane (TAP) block is a regional analgesia technique commonly used in colorectal ERAS protocols, particularly in the laparoscopic surgery setting. Clinical trial data demonstrate TAP block with liposomal bupivacaine ([LB]; Exparel®, bupivacaine liposome injectable suspension; Pacira Pharmaceuticals, Inc., Parsippany, NJ, USA) to be an effective opioid-sparing approach for controlling pain after colorectal surgery. However, clinical trials poorly address patient factors that might affect outcomes using this approach. This editorial provides the author’s personal experience and opinions regarding the optimal use of LB in multimodal management of somatic versus visceral pain and in complex cases, including patients with ulcerative colitis (UC) or other intense visceral inflammatory processes.
ISSN:1178-7090
1178-7090
DOI:10.2147/JPR.S168817